Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10710)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Okano K, Suzuki Y. Strategies for early detection of resectable pancreatic cancer. World J Gastroenterol 2014; 20(32): 11230-11240 [PMID: 25170207 DOI: 10.3748/wjg.v20.i32.11230] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11230.htm |
| Number | Citing Articles |
| 1 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 2 |
Toru Yoshikawa, Tomoyuki Abe, Hironobu Amano, Keiji Hanada, Tomoyuki Minami, Tsuyoshi Kobayashi, Shuji Yonehara, Masahiro Nakahara, Hideki Ohdan, Toshio Noriyuki. Metachronous triple cancer associated with Peutz–Jeghers syndrome treated with curative surgery: a case report. Surgical Case Reports 2018; 4(1) doi: 10.1186/s40792-018-0492-6
|
| 3 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 341 doi: 10.1002/9783527838561.ch15
|
| 4 |
Přemysl Frič, Aleksi Šedo, Jan Škrha, Petr Bušek, Martin Laclav, Pavel Škrha, Miroslav Zavoral. Early detection of sporadic pancreatic cancer: time for change. European Journal of Gastroenterology & Hepatology 2017; 29(8): 885 doi: 10.1097/MEG.0000000000000904
|
| 5 |
Dokyoon Moon, Hongbeom Kim, Youngmin Han, Yoonhyeong Byun, Yoojin Choi, Jaeseung Kang, Wooil Kwon, Jin‐Young Jang. Preoperative carbohydrate antigen 19‐9 and standard uptake value of positron emission tomography‐computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(10): 1133 doi: 10.1002/jhbp.845
|
| 6 |
Alessandro Cucchetti, Giorgio Ercolani, Matteo Cescon, Giovanni Brandi, Giovanni Taffurelli, Lorenzo Maroni, Matteo Ravaioli, Raffaele Pezzilli, Antonio Daniele Pinna. Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer. Pancreas 2016; 45(5): 714 doi: 10.1097/MPA.0000000000000523
|
| 7 |
|
| 8 |
Shounak Majumder, Suresh T Chari, David A Ahlquist. Molecular detection of pancreatic neoplasia: Current status and future promise. World Journal of Gastroenterology 2015; 21(40): 11387-11395 doi: 10.3748/wjg.v21.i40.11387
|
| 9 |
Xin Guo, Xiaohui Lv, Cheng Fang, Xing Lv, Fengsong Wang, Dongmei Wang, Jun Zhao, Yueyun Ma, Yu Xue, Quan Bai, Xuebiao Yao, Yong Chen. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. International Journal of Cancer 2016; 139(8): 1821 doi: 10.1002/ijc.30227
|
| 10 |
Esther Mena, Sara Sheikhbahaei, Mehdi Taghipour, Abhinav K. Jha, Esther Vicente, Jennifer Xiao, Rathan M. Subramaniam. 18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas. Clinical Nuclear Medicine 2017; 42(1): e16 doi: 10.1097/RLU.0000000000001446
|
| 11 |
Randall E. Brand, Jan Persson, Svein Olav Bratlie, Daniel C. Chung, Bryson W. Katona, Alfredo Carrato, Marién Castillo, Julie Earl, Arto Kokkola, Aimee L. Lucas, A. James Moser, Corinne DeCicco, Linda Dexlin Mellby, Thomas C. King. Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study. Clinical and Translational Gastroenterology 2022; 13(3): e00468 doi: 10.14309/ctg.0000000000000468
|
| 12 |
Frank Zimmermann, Alexandros Papachristofilou, Viviane Hess, Christoph Kettelhack. Nur in seltenen Fällen besteht die Chance auf Heilung. Info Onkologie 2015; 18(5): 45 doi: 10.1007/s15004-015-0712-1
|
| 13 |
WanPeng Xin, Shuju Tu, Siqing Yi, Yuanpeng Xiong, Kang Fang, Gen Sun, Weidong Xiao. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer. Gene 2024; 897: 148078 doi: 10.1016/j.gene.2023.148078
|
| 14 |
Mariko Tanaka, Shumpei Ishikawa, Tetsuo Ushiku, Teppei Morikawa, Takayuki Isagawa, Makoto Yamagishi, Hiroyuki Yamamoto, Hiroto Katoh, Kimiko Takeshita, Junichi Arita, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo, Masashi Fukayama. EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis. Oncotarget 2017; 8(59): 99552 doi: 10.18632/oncotarget.20601
|
| 15 |
Efstathios T. Pavlidis, Theodoros E. Pavlidis. Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review. Journal of Investigative Surgery 2018; 31(1): 54 doi: 10.1080/08941939.2016.1269854
|
| 16 |
Yan-Rong Wen, Xia-Wen Lin, Yu-Wen Zhou, Lei Xu, Jun-Li Zhang, Cui-Ying Chen, Jian He. N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer. World Journal of Gastrointestinal Oncology 2024; 16(3): 659-669 doi: 10.4251/wjgo.v16.i3.659
Abstract(88) |
Core Tip(73) |
Full Article(HTML)(431)
|
Full Article with Cover (PDF)-5638K(16)
|
Full Article (Word)-727K(0)
|
Audio-1510K(0)
|
Peer-Review Report-170K(9)
|
Answering Reviewers-54K(8)
|
Supplementary Material-377K(8)
|
Full Article (PDF)-5370K(28)
|
Full Article (XML)-95K(14)
|
Times Cited (0)
|
Total Visits (1042)
|
Open
|
| 17 |
Linda D. Mellby, Andreas P. Nyberg, Julia S. Johansen, Christer Wingren, Børge G. Nordestgaard, Stig E. Bojesen, Breeana L. Mitchell, Brett C. Sheppard, Rosalie C. Sears, Carl A.K. Borrebaeck. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. Journal of Clinical Oncology 2018; 36(28): 2887 doi: 10.1200/JCO.2017.77.6658
|
| 18 |
Přemysl Frič, Jan Škrha, Aleksi Šedo, Petr Bušek, Martin Laclav, Bohuš Bunganič, Miroslav Zavoral. Precursors of pancreatic cancer. European Journal of Gastroenterology & Hepatology 2017; 29(3): e13 doi: 10.1097/MEG.0000000000000810
|
| 19 |
Kaho Hirai, Saiichiro Watanabe, Nozomi Nishijima, Kaoru Shibata, Akane Hase, Tsuyoshi Yamanaka, Masato Inazu. Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells. International Journal of Molecular Sciences 2020; 21(15): 5190 doi: 10.3390/ijms21155190
|
| 20 |
Sonia A. Melo, Linda B. Luecke, Christoph Kahlert, Agustin F. Fernandez, Seth T. Gammon, Judith Kaye, Valerie S. LeBleu, Elizabeth A. Mittendorf, Juergen Weitz, Nuh Rahbari, Christoph Reissfelder, Christian Pilarsky, Mario F. Fraga, David Piwnica-Worms, Raghu Kalluri. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 2015; 523(7559): 177 doi: 10.1038/nature14581
|
| 21 |
Elena Incerti, Emilia G. Vanoli, Sara Broggi, Calogero Gumina, Paolo Passoni, Najla Slim, Claudio Fiorino, Michele Reni, Paola Mapelli, Mauro Cattaneo, Silvia Zanon, Riccardo Calandrino, Luigi Gianolli, Nadia Di Muzio, Maria Picchio. Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. Nuclear Medicine Communications 2019; 40(10): 1072 doi: 10.1097/MNM.0000000000001065
|
| 22 |
Chuan-long Zhang, Qian Shen, Fu-dong Liu, Fan Yang, Meng-qi Gao, Xiao-chen Jiang, Yi Li, Xi-yuan Zhang, Ge-er En, Xue Pan, Bo Pang. SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44646-x
|
| 23 |
Přemysl Frič, Jan Škrha, Aleksi Šedo, Tomaš Zima, Petr Bušek, Klára Kmochová, Martin Laclav, Bohuš Bunganič, Svatopluk Solař, Petr Hrabal, František Bělina, Pavel Záruba, Pavel Škrha, Miroslav Zavoral. Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers. European Journal of Gastroenterology & Hepatology 2016; 28(12): e33 doi: 10.1097/MEG.0000000000000727
|
| 24 |
Ernesto Punzi, Claudio Carrubba, Andrea Contegiacomo, Alessandro Posa, Pierluigi Barbieri, Davide De Leoni, Giulia Mazza, Alessandro Tanzilli, Alessandro Cina, Luigi Natale, Evis Sala, Roberto Iezzi. Interventional Radiology in the Treatment of Pancreatic Adenocarcinoma: Present and Future Perspectives. Life 2023; 13(3): 835 doi: 10.3390/life13030835
|
| 25 |
Hanno Matthaei, Alexander Semaan, Ralph H. Hruban. The genetic classification of pancreatic neoplasia. Journal of Gastroenterology 2015; 50(5): 520 doi: 10.1007/s00535-015-1037-4
|
| 26 |
Marzieh Rezaei, Ahmad Hosseini, Saman Nikeghbalian, Abbas Ghaderi. Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas. Pancreatology 2017; 17(2): 303 doi: 10.1016/j.pan.2017.02.003
|
| 27 |
Chris M. Lindquist, Frank H. Miller, Nancy A. Hammond, Paul Nikolaidis. Pancreatic cancer screening. Abdominal Radiology 2018; 43(2): 264 doi: 10.1007/s00261-017-1308-z
|
| 28 |
Min Young Yoo, Yoo-Seok Yoon, Min Seok Suh, Jai Young Cho, Ho-Seong Han, Won Woo Lee. Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Medicine 2020; 99(35): e21829 doi: 10.1097/MD.0000000000021829
|
| 29 |
Katherine A. Baugh, Nicole Villafane, Carlos Farinas, Sadhna Dhingra, Eric J. Silberfein, Nader N. Massarweh, H. Tran Cao, William E. Fisher, George Van Buren. Pancreatic Incidentalomas: A Management Algorithm for Identifying Ectopic Spleens. Journal of Surgical Research 2019; 236: 144 doi: 10.1016/j.jss.2018.11.032
|
| 30 |
Yongping Zhou, Ting Shan, Wenzhou Ding, Zhiyuan Hua, Yijun Shen, Zhihua Lu, Bo Chen, Tu Dai. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo‐YAP signaling. Journal of Cellular Physiology 2018; 233(8): 5805 doi: 10.1002/jcp.26357
|
| 31 |
Márton Benke, Nelli Farkas, Péter Hegyi, Benedek Tinusz, Patrícia Sarlós, Bálint Erőss, Kata Szemes, Nóra Vörhendi, Zsolt Szakács, Ákos Szücs. Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis. Pathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610266
|
| 32 |
Eramah Ermiah, Mona Eddfair, Othman Abdulrahman, Mohamed Elfagieh, Abdalla Jebriel, Mona Al‑Sharif, Mourad Assidi, Abdelbaset Buhmeida. Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma. Molecular and Clinical Oncology 2022; 17(2) doi: 10.3892/mco.2022.2559
|
| 33 |
Dongyong Zhu, Lisha Wang, Hanfei Zhang, Jie Chen, Yanfang Wang, Sama Byanju, Meiyan Liao. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma. Medicine 2017; 96(33): e7813 doi: 10.1097/MD.0000000000007813
|
| 34 |
Xinjin Gu, Ruiquan Zhou, Chenggang Li, Rong Liu, Zhiming Zhao, Yuanxing Gao, Yong Xu. Preoperative maximum standardized uptake value and carbohydrate antigen 19–9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5691-4
|